Full Press Release Details
Medical Appoints Kevin Schmid as Chief Operating Officer
brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturing
Diego, CA / ACCESSWIRE / July 26, 2022 / Modular Medical, Inc. (the
"Company" or "Modular Medical")(NASDAQ:MODD) today announced that it has appointed industry veteran Kevin
Schmid as its Chief Operating Officer. Mr. Schmid brings extensive operations and business
development leadership experience in diabetes and drug delivery. As Vice President of Operations and Business Development at Insulet
Corporation, he was instrumental in the development, manufacturing, and commercialization of wearable smart drug delivery pumps
such as the Omnipod Diabetes Management System, the Amgen Neulasta On Body Injector, and the Ferring Pharmaceutical LutrePulse
System. His work ranged from concept and product development to scaling multi-million unit global supply chains and high volume
manufacturing operations.
recently the Chief Executive Officer of Common Sensing, a designer and manufacturer of disposable injector pen dose monitoring
and reporting technology. Common Sensing was sold to Bigfoot Biomedical in 2021.
addition to the Modular Medical team adds greater industry depth and extensive manufacturing experience and relationships to enable
MODD's transition to commercialization. Kevin will have a very significant role in Modular Medical's strategic direction
and growth," said Paul DiPerna, Modular Medical's President and Chief Technology Officer.
Modular Medical's insulin delivery platform represents a tremendous opportunity to bring an easy-to-use, cost-effective
insulin delivery system to millions of people managing diabetes every day. I am excited to join the team," said Mr. Schmid.
a member of the board of directors of Eitan Medical, an Israel-based provider of connected infusion and wearable drug delivery
solutions. He has held previous roles at the Stevanato Group and Bose Corporation.
Modular Medical, Inc. (NASDAQ:MODD) is a development-stage medical device company that intends to launch
the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff
between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Our mission
is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers"
and providing "diabetes care for the rest of us."
founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding MODD, Mr.
DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump.
is available at https://modular-medical.com.
trademarks mentioned herein are the property of their respective owners.
Chief Executive Officer
Modular Medical, Inc.
SOURCE: Modular Medical,